A Framework for Personalized Medicine Integration in Community Pharmacy Practice

Thesis Abstract

The integration of personalized medicine into community pharmacy practice offers a promising avenue to enhance patient outcomes through tailored pharmacotherapy, yet its systematic implementation remains limited due to existing structural, knowledge, and attitudinal barriers. This study aims to develop a comprehensive framework to facilitate the seamless incorporation of personalized medicine principles within community pharmacy settings. The specific objectives include evaluating current practices and perceptions of pharmacists regarding personalized medicine, identifying barriers and facilitators to its adoption, and formulating an evidence-based implementation framework grounded in relevant theoretical models. Employing a mixed-methods research design, the study combines quantitative surveys and qualitative interviews to garner a multidimensional understanding of community pharmacists' readiness and the contextual factors influencing personalized medicine integration. The population comprises licensed community pharmacists practicing in urban and semi-urban areas within a defined metropolitan region, with a target sample size of 300 participants for the quantitative component, selected through stratified random sampling to ensure demographic and practice diversity. Additionally, 30 pharmacists will be purposively sampled for in-depth semi-structured interviews to explore nuanced perspectives and contextual intricacies. Data collection instruments include a structured questionnaire to assess pharmacists' knowledge, attitudes, perceived barriers, and perceived facilitators related to personalized medicine, complemented by interview guides designed to delve into contextual and organizational factors. Validity and reliability of the survey instrument will be established through expert review and pilot testing, with reliability confirmed via Cronbach’s alpha exceeding 0.8. Interviews will be audio-recorded, transcribed verbatim, and subjected to thematic analysis using NVivo software, with coding guided by the Consolidated Framework for Implementation Research (CFIR). Quantitative data will be analyzed using descriptive statistics, correlation analysis, and multiple regression to determine predictors of readiness for personalized medicine integration. Qualitative data will undergo thematic analysis grounded in Braun and Clarke’s approach, enriching the understanding of contextual barriers and enablers. The integrated findings are expected to reveal significant knowledge gaps, attitudinal barriers, and systemic challenges, while also identifying key facilitators such as ongoing education, organizational support, and collaborative networks. The study anticipates that the findings will inform the development of a contextually tailored implementation framework based on established change theories such as Rogers’ Diffusion of Innovations and Lewin’s Change Management Model. This framework aims to guide policymakers, pharmacy educators, and practitioners in adopting personalized medicine strategies, including pharmacogenomic testing, tailored counseling, and individualized medication management, into routine community pharmacy workflows. It is expected that the proposed framework will significantly contribute to pharmacy practice literature by providing a structured, evidence-based model for integrating personalized medicine, thereby enhancing pharmacists’ roles in precision healthcare. The study underscores the importance of educational interventions, organizational restructuring, and policy support to facilitate this integration effectively. The main conclusion emphasizes that a systematic, theory-informed, and context-sensitive approach is essential for embedding personalized medicine into community pharmacy practice, ultimately improving patient safety, medication efficacy, and overall health outcomes. Recommendations include the implementation of targeted training programs for pharmacists, development of supportive policies, and establishment of collaborative platforms between healthcare providers. Future research directions are suggested to empirically validate the proposed framework in diverse geographical and practice settings, ensuring its adaptability and sustainability across different community pharmacy contexts.